mph501

[mph501 @MPH501]

FDA to allow COVID-19 treatments with blood from survivors #COIVD19 #FDA https://t.co/duXnrDzoC3

[mph501 @MPH501]

Moderna's COVID-19 vaccine could reach healthcare workers this fall #COVID19 https://t.co/Dxo7mVS5zb

[mph501 @MPH501]

Global Deaths Due to Various Causes and COVID-19 #pandemic #COIVD19 https://t.co/bxtKUD5g3f

[mph501 @MPH501]

Looking beyond COVID-19's spike protein for the next wave of vaccines #covid19 #covid19vaccine https://t.co/PJXvtQg7QO

[mph501 @MPH501]

Missed our biosimilars webinar? We shared how to develop a sound global strategy for producing these innovative therapeutics. Watch the webinar recording here: https://t.co/eiNBRpFQPV

[mph501 @MPH501]

ake a 3D virtual tour from the comfort and safety of your home or office: Explore centralized CMC analytical support - characterization, formulation, QC release and stability, etc. – at one of our four global CMC facilities. #BioCMC #drugdevelopment https://t.co/sYmq5Iaw0m

[mph501 @MPH501]

CASE STUDY: Rapid & Robust #Preclinical & #ClinicalDevelopment of CAR-T Cell Therapies. Find out how Covance helped the sponsor identify lead assets, navigate through IND-submission and conduct Phase I/II dosing studies in an accelerated timeframe. https://t.co/KpEJDV4Ww4

[mph501 @MPH501]

Creating a Robust Reimbursement Support Program for #Biosimilars. Learn how a robust reimbursement program is critical to launching a successful biosimilar product. #patientsupport https://t.co/IOCfQtVINP

[mph501 @MPH501]

Need support to advance your #ophthalmic drug, device or diagnostic? Look no further than our experienced team with specialized expertise spanning #preclinical to #clinical and post-market studies. #clinicalstudies https://t.co/v3wabZOCCx

[mph501 @MPH501]

Covance Central Laboratory Services is committed to our corporate mission to improve health and improve lives. Our labs are well positioned to support #biopharmaceutical companies conducting clinical trials for #COVID19 #vaccines and therapeutics. https://t.co/H0Oc3GuaB1

[mph501 @MPH501]

Don’t miss our Feb. 24th session at Outsourcing in Clinical Trials West Coast 2021, “Proactively Addressing Complexity in Early Clinical Development.” You’ll learn about ensuring your early clinical strategies align with your desired endpoints & much more. https://t.co/6aR1gzofUf

[mph501 @MPH501]

Clinical trial in hospitalized COVID-19 patients evaluates long-acting antibody therapy #clinicaltrials #COVID https://t.co/BmHVWYTVXR

[mph501 @MPH501]

Four potential COVID-19 therapeutics enter Phase 2/3 testing in NIH ACTIV-2 trial #COVID19 https://t.co/o4TlPf2Q5U

[mph501 @MPH501]

The Science Behind Why New COVID Variants Are Spreading Faster #COVIDvariants #COVID19 https://t.co/Y8ag1kUfYL

[mph501 @MPH501]

World’s largest COVID-19 drug trial identifies second compound that cuts risk of death #COVID19 https://t.co/QEoWFAX9Ep

[mph501 @MPH501]

Dr. Rebecca Lee Crumpler: The first Black woman M.D. in the US #BlackHistoryMonth https://t.co/1aE1cpLRpc

[mph501 @MPH501]

Antibody infusions prevent acquisition of some HIV strains, NIH studies find #HIV https://t.co/bEP4G7iZba

[mph501 @MPH501]

Preclinical and Translational Research Webinar Series—Foundation Fighting Blindness https://t.co/ZZtXXv1qSj

[mph501 @MPH501]

Labcorp is pleased to announce the appointment of Maryland Franklin, PhD, as Vice President and Enterprise Head of Cell & Gene Therapy (CGT) for Labcorp’s Drug Development business unit, Covance. Read the full announcement. https://t.co/1bJJXplBTa

[mph501 @MPH501]

Johnson & Johnson's single-shot vaccine candidate triggers long-term immune response in early study #COVIDvaccine #COVID19 https://t.co/Sg75gtjOxn